Fulcrum Therapeutics (FULC) EBIT Margin (QoQ) (2020 - 2023)
Fulcrum Therapeutics (FULC) EBIT Margin (QoQ) (2020 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Fulcrum Therapeutics | 286.57 Mn | 286.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 40,151.00 |
| Sep 30, 2023 | -51,392.00 |
| Jun 30, 2023 | 636,982.00 |
| Mar 31, 2023 | -538,754.00 |
| Dec 31, 2022 | -202,490.00 |
| Sep 30, 2022 | -23,967.00 |
| Jun 30, 2022 | -81,607.00 |
| Mar 31, 2022 | -53,723.00 |
| Dec 31, 2021 | -4,491.00 |
| Sep 30, 2021 | 2,839.00 |
| Jun 30, 2021 | -9,338.00 |
| Mar 31, 2021 | 6,512.00 |
| Dec 31, 2020 | 61,277.00 |
| Sep 30, 2020 | -23,757.00 |
| Jun 30, 2020 | 170,993.00 |